John Stellini has a general corporate and securities law practice, with an emphasis on the representation of emerging companies, venture capital funds and public companies.
Cooley advised Atalan Tech, a women-led, mission-driven company at the forefront of artificial intelligence technology for predicting and preventing clinician burnout and turnover in healthcare systems, on its $2.5 million seed financing.
Cooley advised Cellares, the first integrated development and manufacturing organization dedicated to clinical and industrial-scale cell therapy manufacturing, on its $255 million financing.
ACELYRIN Announces Pricing of Upsized Initial Public Offering
May 15, 2023
Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.
Cooley advised Lively on its $80 million Series C funding round. Partner Gordon Ho led the Cooley team advising Lively, which created the modern health savings account (HSA).
Cooley advised AiFi on its $65 million Series B funding round. Partner Gordon Ho led the Cooley team advising AiFi, which is a flexible artificial intelligence platform that enables retailers to affordably deploy and scale autonomous shopping solutions.
